MedDataX Logo

Destigmatization Among Primary Health Care Providers

NCT06655792 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-07-11

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to learn if an educational program can reduce stigma toward mental illness among primary health care providers. The main questions it aims to answer are:

* Does the educational program decrease stigma toward mental illness among participants?
* How does the program improve knowledge about mental illness?
* What beliefs about mental illness do participants hold before and after the program? Researcher will compare the intervention group, who will receive the educational program, to a control group that will not receive the program to see if the educational program is effective in reducing stigma and improving knowledge.

Participants will:

Attend educational sessions designed to increase awareness and understanding of mental illness.

Complete questionnaires about their attitudes, beliefs, and knowledge regarding mental illness before and after the program.

Provide demographic information and professional background details.

Conditions

  • Stigma of Mental Illness

Interventions

OTHER

Educational Program on Mental Illness Stigma Reduction

The intervention consists of an 8-session educational program designed to reduce stigma towards mental illness among primary healthcare providers. The program includes lectures and multimedia presentations on mental health, stigma, and its effects. It engages participants in role-playing exercises to simulate the experience of stigma and improve communication skills. Group discussions allow participants to reflect on personal beliefs and attitudes, and case studies provide real-world examples of stigma and intervention strategies. The program spans four days, with two sessions per day, each lasting 50-60 minutes.

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-12-01
Completion
2025-12-15

Countries

  • Iraq

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06655792 on ClinicalTrials.gov